0000950170-24-001847.txt : 20240104 0000950170-24-001847.hdr.sgml : 20240104 20240104160717 ACCESSION NUMBER: 0000950170-24-001847 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240102 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bair Teresa Brophy CENTRAL INDEX KEY: 0001813058 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37620 FILM NUMBER: 24511864 MAIL ADDRESS: STREET 1: C/O KURA ONCOLOGY, INC. STREET 2: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kura Oncology, Inc. CENTRAL INDEX KEY: 0001422143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 611547851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 500-8800 MAIL ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP III DATE OF NAME CHANGE: 20071227 4 1 ownership.xml 4 X0508 4 2024-01-02 0001422143 Kura Oncology, Inc. KURA 0001813058 Bair Teresa Brophy C/O KURA ONCOLOGY, INC. 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 false true false false Chief Legal Officer false Common Stock 2024-01-02 4 A false 46250 0 A 71032 D Option to purchase common stock 15.36 2024-01-02 4 A false 92500 0 A 2034-01-01 Common Stock 92500 92500 D Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/25, 1/26/26, 1/26/27 and 1/26/28. Includes 1,657 shares acquired on May 17, 2023 pursuant to the Issuer's Employee Stock Purchase Plan. This option vests in 48 equal monthly installments commencing on the grant date. Teresa Bair 2024-01-04